2015
8.20.15
790 Talk Now Heidi Harris Show: Interview with Dr. Gregory P. Cosgrove on pulmonary fibrosis
03.26.15
St. Louis Post-Dispatch: Lung transplant saves man who had five years to live
03.13.15
ChicagoTribune.com: Feeling short of breath? It could be something serious*
03.12.15
The Bulletin: Drugs for rare disease out of reach for Bend patient
02.05.15
Daily Southtown: Chicago-based Pulmonary Fibrosis Foundation expands first-of-its-kind care center network; care center network program piloted at University of Chicago
01.05.15
WGNU: PFF Radio Media Tour**
*posted by more than 1,100 online publications including Tribune
**interviews aired on more than 13 broadcast outlets nationwide
2014
11.5.14
WGN: Two new drug options give hope to those suffering pulmonary fibrosis
10.17.14
Pulmonary Hypertension News: 2 IPF drugs get FDA approval; Pulmonary Fibrosis Foundation's Praise
10.17.14
BioWorld: Air pair Esbriet, Ofev tied for FDA first in IPF; Roche rolling price dice but BI yet to disclose
10.16.14
Tech Times: FDA approval of Roche, Boehringer drugs for idiopathic pulmonary fibrosis is a big step forward
10.16.14
The Science Times: FDA approves two separate drugs for killer lung disease
10.16.14
Uncover Michigan: First two drugs for treatment of fatal lung disease approved by FDA
10.16.14
Capital OTC: FDA approves two drugs (Esbriet, Ofev) for treating fatal lung disease
10.16.14
Delhi Daily News: FDA approves first two drugs for fatal lung disease
10.15.14
San Francisco Business Times: InterMune wins FDA OK for lung-scarring disease drug at center of Roche deal
10.15.14
San Francisco Gate: Roche’s InterMune wins FDA approval for lung disease treatment
10.15.14
The Examiner: The FDA has approved two drugs for a fatal lung disease
10.15.14
The Street: FDA approves competing lung disease drugs from Roche and Boehringer